Ilse J. J Dons-Sinke

Ilse J. J Dons-Sinke

Auto-generated profile, based on publicly available information

Ilse J. J Dons-Sinke

Department of Anesthesiology, Erasmus MC Sophia, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2016 in Case Reports in Anesthesiology
Verified
Journal Article
Open access
PDF file
ADA. L. M. J. van der Knijff-Van Dortmont
A. L. M. J. van der Knijff-Van Dortmont
MDMaaike Dirckx
Maaike Dirckx
JDJ. J. Duvekot
J. J. Duvekot
JRJ. W. Roos-Hesselink
J. W. Roos-Hesselink
ACA. Gonzalez Candel
A. Gonzalez Candel
IDI. J. J. Dons-Sinke
I. J. J. Dons-Sinke
SCN5A gene mutations can lead to ion channel defects which can cause cardiac conduction disturbances. In the presence of specific ECG characteristics, this mutation is called Brugada syndrome. Many drugs are associated with adverse events, making anesthesia in patients with SCN5A gene mutations or Brugada syndrome challenging. In this case report, we describe a pregnant patient with this mutation who received epidural analgesia using low dose ropivacaine and sufentanil during labour.

1 January 2014 in Case Reports in Anesthesiology
Verified
Journal Article
Open access
PDF file
IDI. J. J. Dons-Sinke
I. J. J. Dons-Sinke
MDM. Dirckx
M. Dirckx
GSG. P. Scoones
G. P. Scoones
The introduction of enzyme replacement therapy and the resultant stabilisation or improvement in mobility and respiratory muscle function afforded to patients with late-onset Pompe may lead to an increased number of Pompe patients prepared to accept the challenges of parenthood. In this case report, we describe our anaesthetic management of two patients with Pompe disease for a caesarean section.

1 June 2026 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
EWEwout C. van der Wal
Ewout C. van der Wal
JDJohannes Duvekot
Johannes Duvekot
IDIlse J. J Dons-Sinke
Ilse J. J Dons-Sinke
RSRobert Jan Stolker
Robert Jan Stolker
SHSanne Elisabeth Hoeks
Sanne Elisabeth Hoeks
CMCaroline van der Marel
Caroline van der Marel
Purpose: Epidural analgesia (EA) is considered safe and advantageous in twin deliveries, yet specific evidence to support this practice is scarce. This systematic review aims to identify the impact of EA on perinatal outcomes during planned vaginal twin deliveries. Methods: A literature search was conducted to identify studies involving vaginal multiple delivery with EA. Newcastle–Ottawa scale quality assessments were performed, and baseline characteristics and perinatal outcomes were extracted. Results: Seven retrospective cohort studies were included. Quality scores ranged from 5 to 8/8 stars. Baseline characteristics and reported outcome measures were heterogenous. When comparing EA to non-EA users, incidence of CS after vaginal trial of labor was similar in one study (13% vs 21%, OR 1.65 [0.70–3.90]), but lower in another study (7% vs 15%, OR 0.0435 [0.022–0.083]). A third study reported a beneficial effect of EA for the second twin only. Anesthesiologic strategies for emergency CS were not reported. Instrumental delivery was increased or similar for women in the EA group. Apgar scores for deliveries using EA were not reduced. Perinatal mortality for the second twin was similar. Conclusion: EA in planned vaginal twin delivery seems to be associated with a reduced incidence of CS, a higher risk of assisted delivery, and an increased second-stage length. However, evidence of the associated consequences for mothers and neonates is limited. Given the limited number of eligible studies and reported outcomes, further research is needed to definitively assess the current practice of routine epidural administration for multiple deliveries, and to correctly inform women of its risks/benefits.

4 June 2026 in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Verified
Journal Article
Open access
EWEwout C. van der Wal
Ewout C. van der Wal
JDJohannes Duvekot
Johannes Duvekot
LDLlse J.J. Dons-Sinke
Llse J.J. Dons-Sinke
RSRobert Jan Stolker
Robert Jan Stolker
SHSanne Elisabeth Hoeks
Sanne Elisabeth Hoeks
CMCaroline van der Marel
Caroline van der Marel
Obese pregnant women (body mass index ≥ 30 kg/m2) often receive epidural analgesia (EA) during their deliveries. However, there is scarce evidence on the effect of EA on maternal and perinatal outcomes in these women. The goal of this study is to evaluate outcomes in obese women receiving EA during their planned vaginal deliveries. Patient records of obese women undergoing a planned vaginal delivery from January 2018 until December 2023 in a tertiary care center were screened. Women were stratified into two groups depending on whether or not they received EA during their deliveries. EA was provided after shared decision making between provider and mother. Baseline characteristics and perinatal outcomes were collected for both groups. Primary outcomes were conversion to cesarean section (CS) and reduced Apgar scores (<7 at 5 min). Secondary outcomes were mode of delivery, type of anesthesia, estimated blood loss, episiotomies, perineal ruptures, hospital length of stay, fetal umbilical artery pH and base excess. Using inverse probability of treatment weights, primary outcomes per group were adjusted for baseline characteristics in a logistic regression model. 259 women received EA, 144 did not. Women with EA had lower gravidity and parity, more often induction of labor and delivered children with higher birthweights. In total 88 (22%) women in both groups required secondary CS. General anesthesia was avoided for all 64 women with EA. In the non-EA group, general anesthesia was used for seven out of 24 women. After adjustment, conversion to CS (OR 0.984, CI 0.542–1.786, P = 0.957) and reduced Apgar scores (OR 1.138, CI 0.375–3.458, P = 0.820) were not significantly different. Secondary outcomes (unadjusted) showed several differences. EA was associated with more vacuum deliveries (16% vs 2%, P < 0.001), more episiotomies (18% vs 7%, P = 0.003), higher mean blood loss (523 ml vs 351 ml, P < 0.001), and longer mean length of hospital admittance (4.3 days vs 3.5, P < 0.001). Women with a BMI ≥ 30 kg/m2 receiving EA for planned vaginal delivery showed similar conversion to CS and similar Apgar scores, when compared to obese women without EA. Secondary maternal outcomes were less beneficial for the group receiving EA, but fetal outcomes were not. When conversion to surgical delivery was required, general anesthesia was avoided in 100% of women with EA, while 29% of women without EA required general anesthesia, although fetal outcomes were not worse in this group. In conclusion, early epidural placement for intended vaginal delivery in obese women is safe for mother and child and may prevent the need for general anesthesia for conversion to CS.